ROSENBLUM MARK J (Exec VP Finance, Interim CFO) received a stock award from DECOY THERAPEUTICS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 5/5/2021ACC: 0001615219-21-000042
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+9.56K
Net shares
Net buyer
$5.4K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
9.56K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.56K
Price / share
$0.57
Trade value
$5.42K
% of position
57.2%
5/3/2021
16.72K→26.29K
Total
Net shares
+9.56K
Net value
$5.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/3/2021 | A · Award | +9.56K | $0.57 | $5.42K | 57.2% | 16.72K | 26.29K |
| Total | +9.56K | $5.42K | ||||||
Derivative Transactions0
No derivative transactions reported